Global Drugs for Malaria Market Analysis 20112017 and Forecast 20182023 [Report Updated: 02102017] Prices from USD $2980
Snapshot
Drugs for malaria or antimalarial medications are also known as antimalarial drugs. Antimalarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of onecelled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
The global Drugs for Malaria market will reach Volume Million USD in 2017 and CAGR xx% 20112017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Drugs for Malaria by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage Market Size Forecast, Major Company of Product Type etc.:
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Company Coverage Sales Revenue, Price, Gross Margin, Main Products etc.:
Guilin Pharmaceutical
Cipla
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
Application Coverage Market Size Forecast, Different Demand Market by Region, Main Consumer Profile etc.:
Prevention
Treatment
Others
Region Coverage Regional Output, Demand Forecast by Countries etc.:
North America
Europe
AsiaPacific
South America
Middle East Africa
Original Article: Global Drugs for Malaria Market Analysis 20112017 and Forecast 20182023 [Report Updated: 02102017] Prices from USD $2980
